Exactly eight years ago, in 2016, when a reality TV star became US president, the global markets went into sharp decline on the day of surprise victory. In 2024, the reaction is the opposite – markets are rejoicing at his return. While there is nothing wrong in having a party, better be cognizant of some of the things the next US president brings to the table. One would be tariff wars. While China will be the main focus, there are areas where India will be in the picture. But there is one sector that is unlikely to face any trouble: Pharmaceuticals. There are reasons why it might escape the headwinds, in some cases the change in regime might act as another tailwind.
